Transcriptomic analysis implicates the involvement of RBM20 in Fuchs’ endothelial corneal dystrophy with TCF4 repeat expansion
PLOS One · 2025
DOI: 10.1371/journal.pone.0332512 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Xunzhi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Hauptthemen laut MEDLINE: Fuchs' Endothelial Dystrophy, Transcription Factor 4, Trinucleotide Repeat Expansion, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Eye Institute, Research to Prevent Blindness, Harrington Discovery Institute, University Hospitals.
Abstract (Originalsprache)
Background
Late-onset Fuchs’ endothelial corneal dystrophy (FECD) is a degenerative disease of cornea manifesting during the fourth decade of life or later. An intronic trinucleotide repeat expansion (CTG18.1) in the transcription factor 4 ( TCF4 ) gene is estimated to account for two thirds of FECD cases. There is a high degree of similarity between the transcriptomic profiles with (RE+) and without (RE-) the expansion. The molecular mechanisms of FECD and the difference between the two FECD types remain to be elucidated.
Method
Analyses were based on publicly available RNA sequencing datasets of human corneal endothelial tissues. We compared the distributions of differentially expressed genes between the RE+ and RE- transcriptomic profiles for a given co-expression network module. Upstream regulator analysis, alternative splicing analysis, motif enrichment analysis, and structure prediction were conducted.
Results
The expression levels of ribonucleic acid binding motif protein 20 ( RBM20 ) were upregulated in both RE+ cases and RE+ controls. Consistently, its motif was enriched in the skipped exon events of RE+ subjects compared with RE- subjects. There were skipped exon events in three genes— DST , FNBP1 and SORBS1 — consistently identified in RE+ subjects out of the documented RBM20 target genes in the literature.
Conclusion
RBM20 may represent an RE+ specific factor in the pathogenesis of FECD. The increase of RBM20 expression in RE+ individuals may contribute to the disease by repressing the inclusion of exons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
- Children's Medical Center Research Institute, Dallas, Texas, United States of America.
- Department of Statistics, University of Wisconsin, Madison, Wisconsin, United States of America.
- Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
- Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
- O'Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Förderung
- National Eye Institute
- Research to Prevent Blindness
- Harrington Discovery Institute, University Hospitals
Zitieren
APA
Zhang, X., Yu, Z., Westfall, A. K., Han, K., Mootha, V. V., & Xing, C. (2025). Transcriptomic analysis implicates the involvement of RBM20 in Fuchs’ endothelial corneal dystrophy with TCF4 repeat expansion. PLOS One. https://doi.org/10.1371/journal.pone.0332512
Vancouver
Zhang X, Yu Z, Westfall AK, Han K, Mootha VV, Xing C. Transcriptomic analysis implicates the involvement of RBM20 in Fuchs’ endothelial corneal dystrophy with TCF4 repeat expansion. PLOS One. 2025. doi:10.1371/journal.pone.0332512
BibTeX
@article{Zhang2025,
author = {Zhang, Xunzhi and Yu, Ze and Westfall, Aundrea K and Han, Kunyi and Mootha, V Vinod and Xing, Chao},
title = {Transcriptomic analysis implicates the involvement of RBM20 in Fuchs’ endothelial corneal dystrophy with TCF4 repeat expansion},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332512}
}
EUVIMED